394 results on '"Fremeaux-Bacchi, V."'
Search Results
2. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions
3. Syndromes hémolytiques et urémiques (SHU) et syndromes de microangiopathie thrombotique apparentés : traitement et pronostic
4. SHU et syndromes de microangiopathie thrombotique apparentés : épidémiologie, physiopathologie et tableaux cliniques
5. Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult
6. Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
7. Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation
8. POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
9. Syndrome hémolytique et urémique lié à des anomalies du complément
10. Angio-œdèmes héréditaires : dépistage et caractérisation des grandes délétions sur le gène du C1 inhibiteur
11. Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report
12. Activation de la voie alterne du complément dans les formes sévères de COVID-19
13. Les syndromes hémolytiques et urémiques de l’adulte associés aux infections à Escherichia coli producteur de Shigatoxine en France de 2009 à 2017
14. Analyse du complément chez des patients ayant une microangiopathie thrombotique associée au lupus : identification de variants rares du facteur I
15. « Ce qui me gêne, ce n’est pas mon âge… ». Diagnostic de glomérulonéphrite à dépôt de C3 sur mutation hétérozygote du facteur H chez une femme de 96 ans
16. Complement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
17. DETECTION OF C3D-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES AT DIAGNOSIS OF HUMORAL REJECTION PREDICTS RENAL GRAFT LOSS: 80
18. Supplement to: Eculizumab in severe Shiga-toxin-associated HUS.
19. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
20. Biological Markers to Predict Recurrence of C3 Glomerulopathies After Renal Transplantation.: Abstract# A41
21. EFFICACY OF ECULIZUMAB IN ALLOGENIC STEM CELL TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY: A RETROSPECTIVE STUDY ON BEHALF THE SOCIETE FRANCAISE DE GREFFE DE MOELLE ET DE THERAPIE CELLULAIRE (SFGM-TC): PH-O057
22. Recurrence of HUS Due to CD46/MCP Mutation After Renal Transplantation: A Role for Endothelial Microchimerism
23. Angioedemas hereditarios y adquiridos por déficit de inhibidor de C1
24. Recurrence of Hemolytic Uremic Syndrome After Renal Transplantation
25. Chapitre 21 - Système du complément
26. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome
27. Jagged1 is a CD46 ligand and disturbance in CD46/Jagged 1 interaction leads to abnormal Th1 function and infections in humans: W04.005
28. Factor H and MCP haplotypes don’t confer susceptibility for C3 glomerulopathy: P184
29. Anti-factor H auto-antibodies in C3 glomerulopathy: P186
30. High prevalence of hybrid genes involving CFH and CFHR1 in atypical Hemolytic Uremic Syndrome: O1
31. Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital
32. Caractérisation clinique et immunologique des formes mixtes associant glomérulonéphrite à C3 et SHU atypique : résultats d’une étude rétrospective multicentrique
33. Le séquençage des gènes de la voie alterne du complément d’une cohorte de néphropathie à IgA sévère révèle une fréquence élevée de variants rares de CFH et une sur-représentation d’un variant pathogène du gène de la thrombomoduline
34. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
35. Different molecular mechanisms of alternative complement pathway dysregulation result in common glomerular endothelial damage and contribute to the pathogenesis of the atypical hemolytic uremic syndrome: A2.09
36. Disseminated Tuberculosis in a Patient with Hereditary C1-inhibitor Deficiency
37. Influence of genotype on clinical characteristics of atypical hemolytic uremic syndrome (aHUS) with pediatric and adult onset: O57
38. Anti-Factor H auto-antibodies in atypical Hemolytic Uremic syndrome and membrano-proliferative glomerulonephritis: Non-univocal histories: O59
39. Complement activation by cytokine-activated neutrophils in the context of Anti-Neutrophil-Cytoplasm Autoantibodies vasculitis: O27
40. Eculizumab in congenital relapsing aHUS/TTP: OC-WE-012
41. Purpura thrombotique thrombocytopénique et autres syndromes de microangiopathie thrombotique
42. Infection par Neisseria meningitidis: Critères cliniques orientant vers un déficit en protéines du complement
43. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome
44. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H
45. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts
46. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
47. Implication de l’activation du complément dans les lésions d’organes notamment rénales de la drépanocytose chez des patients et dans un modèle murin
48. Étude de la susceptibilité individuelle à l’activation/régulation du complément à la surface cellulaire endothéliale : validation d’un nouveau modèle ex vivo
49. Glomérulopathies associées aux anticorps anti-facteur B chez l’adulte
50. Restricted genetic defects underlie human complement C6 deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.